Beyond humanization and de-immunization: tolerization as a method for reducing the immunogenicity of biologics

by Sarah Moniz | Aug 15, 2018

T-cell dependent immunogenicity of protein therapeutics: Preclinical assessment and mitigation

by Sarah Moniz | Aug 15, 2018

Building Better Biotherapeutics and Vaccines by Design: EpiVax, Inc., an Immunology Company

by Adam | Oct 22, 2016

Rhode Island Medical Journal, February 2013. rimed.org/rimedicaljournal/2013-02/2013-02-19-bio-epivax.pdf

Highly Immunogenic Vaccine For Prevention and Therapy of Malignant Mesothelioma

by Adam | Oct 21, 2016

Tregitopes: The active ingredient in IVIG-mediated tolerance induction?

by Adam | Oct 21, 2016